# Boston Scientific closes $435M acquisition of Symetis

Boston Scientific Corporation announced the close of its acquisition of Symetis SA, a Swiss structural heart company, for $435 million in cash. The deal was originally announced on March 30, 2017.

- Type: Acquisition
- Announced: 2017-05-16
- Where: Marlborough, Massachusetts, United States
- Value: $435.0M
- Status: completed
- Products: transcatheter aortic valve implantation devices, ACURATE TA valve system, ACURATE neo/TF valve system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Symetis SA](https://endata.com/companies/23188.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2017-05-16-Boston-Scientific-Closes-Symetis-Acquisition), 2017-05-16: "Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices."
- [truffle.com](https://www.truffle.com/news/truffle-capital-announces-close-symetis-acquisition-435-million-boston-scientific), 2017-05-17: "Truffle Capital announces the close of Symetis acquisition for $435 million by Boston Scientific"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.